Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil

被引:7
|
作者
Dal Pupo, Halan D. [1 ]
Sena, Bianca A. G. [2 ]
Reis, Flavia C. G. [2 ,3 ]
Machado, Lumena [4 ]
Fortes, Silvana T. [5 ]
de Almeida Junior, Joao N. [4 ,6 ]
Godinho, Rodrigo M. C. [7 ]
Rodrigues, Marcio L. [2 ,7 ]
机构
[1] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Programa Posgrad Biol Parasitaria, Rio De Janeiro, Brazil
[2] Fiocruz MS, Inst Carlos Chagas, Curitiba, Parana, Brazil
[3] Fundacao Oswaldo Cruz, CDTS, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Inst Med Trop, Lab Micol Med, Sao Paulo, Brazil
[5] Univ Fed Roraima UFRR, Ctr Estudos Biodiversidade, Lab Micol, Roraima, Brazil
[6] Univ Sao Paulo, Fac Med, Hosp Cent, Sao Paulo, Brazil
[7] Univ Fed Rio de Janeiro, IMPG, Rio De Janeiro, Brazil
关键词
Capsule; Cryptococcal diversity; Glucuronoxylomannan; Glycan heterogeneity;
D O I
10.1016/j.funbio.2019.06.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Species of the Cryptococcus genus comprise environmental, encapsulated fungal pathogens that cause lethal meningitis in immunosuppressed individuals. In humans, fungal uptake of hypocapsular Cryptococcus by macrophages was associated with high fungal burden in the cerebrospinal fluid and long-term patient survival. On the basis of the key role of the cryptococcal capsule in disease, we analyzed the diversity of capsular structures in 23 isolates from pigeon excreta collected in the cities of Boa Vista, Bonfim and Pacaraima, in the state of Roraima (Northern Brazil). All isolates were identified as Cryptococcus neoformans (VNI genotype) by MALDI-TOF mass spectrometry. Through a combination of fluorescence microscopy, flow cytometry, ELISA and spectrophotometric methods, each isolate was characterized at the phenotypical level, which included measurements of growth rates at 30 and 37 degrees C, pigmentation, cell body size, capsular dimensions, serological reactivity, urease production and ability to produce extracellular glucuronoxylomannan (GXM), the main capsular component of C. neoformans. With the exception of melanization, a formidable diversity was observed considering all parameters tested in our study. Of note, hyper and hypo producers of GXM were identified, in addition to isolates with hyper and hypo profiles of reactivity with a polysaccharide-binding monoclonal antibody. Capsular dimensions were also highly variable in the collection of isolates. Extracellular GXM production correlated positively with capsular dimensions, urease activity and cell size. Unexpectedly, GXM concentrations did not correlate with serological reactivity with the cryptococcal capsule. These results reveal a high diversity in the ability of environmental C. neoforrnans to produce capsular components, which might impact the outcome of human cryptococcosis. (C) 2019 British Mycological Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:699 / 708
页数:10
相关论文
共 50 条
  • [1] Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal
    Ferreira, Ana Sofia
    Sampaio, Ana
    Maduro, Ana Paula
    Silva, Ines
    Teles, Fernando
    Martins, Maria da Luz
    Inacio, Joao
    MYCOSES, 2014, 57 (02) : 98 - 104
  • [2] MLST reveals a clonal population structure for Cryptococcus neoformans molecular type VNI isolates from clinical sources in Amazonas, Northern-Brazil
    Silva Rocha, Diego Fernando
    Cruz, Katia Santana
    da Silva Santos, Carla Silvana
    Fernandes Menescal, Lizandra Stephanny
    da Silva Neto, Joao Ricardo
    Pinheiro, Silviane Bezerra
    Silva, Lucyane Mendes
    Trilles, Luciana
    Braga de Souza, Joao Vicente
    PLOS ONE, 2018, 13 (06):
  • [3] Pathogenicity of Cryptococcus neoformans VNI (ST 32) recovered from environmental and clinical isolates in Nigeria
    Paul C.
    Emeka N.
    Comparative Clinical Pathology, 2019, 28 (4) : 1013 - 1024
  • [4] Molecular diversity of serial Cryptococcus neoformans isolates from AIDS patients in the city of Sao Paulo, Brazil
    Martins, Marilena A.
    Pappalardo, Mara C. S. M.
    Melhem, Marcia S. C.
    Pereira-Chioccola, Vera L.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2007, 102 (07): : 777 - 784
  • [5] Genetic characterization of environmental isolates of the Cryptococcus neoformans species complex from Brazil
    Trilles, L
    Lazéra, M
    Wanke, B
    Theelen, B
    Boekhout, T
    MEDICAL MYCOLOGY, 2003, 41 (05) : 383 - 390
  • [6] Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil
    de Oliveira, MTB
    Boekhout, T
    Theelen, B
    Hagen, F
    Baroni, FA
    Lazera, MS
    Lengeler, KB
    Heitman, J
    Rivera, ING
    Paula, CR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) : 1356 - 1359
  • [7] PROTEIN CONJUGATES OF POLYSACCHARIDE FROM CRYPTOCOCCUS NEOFORMANS
    GOREN, MB
    MIDDLEBR.M
    JOURNAL OF IMMUNOLOGY, 1967, 98 (05): : 901 - &
  • [8] Phenotypic Diversity of Cryptococcus neoformans var. neoformans Clinical Isolates from Localized and Disseminated Infections
    Birkenfeld, Zena M.
    Dittel, Nikita
    Harrer, Thomas
    Stephan, Christoph
    Kiderlen, Albrecht F.
    Rickerts, Volker
    MICROORGANISMS, 2022, 10 (02)
  • [9] In vitro susceptibility of Cryptococcus neoformans VNI and Cryptococcus gattii VGII to antifungal drugs from HIV positive and HIV-negative patients in midwest of Brazil
    Favalessa, O. C.
    MYCOSES, 2013, 56 : 64 - 64
  • [10] First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Belem, Para, Brazil
    Costa, Solange do P. S. E.
    Lazera, Marcia dos S.
    Santos, Wallace R. A.
    Morales, Bernardina P.
    Bezerra, Claudia C. F.
    Nishikawa, Marilia M.
    Barbosa, Glaucia G.
    Trilles, Luciana
    do Nascimento, Jose L. M.
    Wanke, Bodo
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (04): : 662 - 664